je.st
news
Tag: allergan
Drugmakers Pfizer, Allergan considering a combination: WSJ
2015-10-29 08:31:31| Biotech - Topix.net
REUTERS: Drugmakers Pfizer Inc and Allergan Plc are considering combining in what could be the biggest merger in the healthcare industry in already busy year, the Wall Street Journal said on Wednesday. The process is in its early stages, and may not yield an agreement, while other details of the talks are unclear, the report said.
Tags: combination
pfizer
wsj
allergan
Amgen, Allergan Biosimilar Avastin Hits In Trial
2015-09-24 17:07:51| Biotech - Topix.net
Amgen and Allergan, which started their collaboration back in 2011 when Allergan was a generic drug maker called Watson Pharmaceuticals, released few details but said the drug ABP 215 had shown clinical equivalence to Avastin as measured by tumor shrinkage, duration of response and progression-free survival. Launched in 2004, Avastin is drawing $7 billion for Roche as a treatment for a variety of different cancers, about 20% to 25% of it from lung cancer.
Tags: trial
hits
amgen
allergan
Allergan and Monster Beverage top the list of the fund's new holdings
2015-09-14 10:18:08| Beverages - Topix.net
The hedge fund FMR LLC in its last quarterly 13F reported a total value of its portfolio of $780 billion, with a decrease of 0.61% since the previous quarter. During Q2 2015, the investor bought 188 new stocks and increased 1,155 of its existing stakes.
Allergan announces positive results from AVYCAZ Phase III studies for treatment of cUTI
2015-09-03 07:58:28| Biotech - Topix.net
Allergan plc. today announced positive topline results from RECAPTURE 1 and 2, the pivotal Phase III studies evaluating the antibiotic AVYCAZ as a treatment for adult hospitalized patients with complicated urinary tract infections , including pyelonephritis.
Allergan may turn sights to Amgen or AbbVie with Teva cash
2015-07-28 18:30:04| Biotech - Topix.net
Allergan Plc says it's “reloaded and ready to move” on further acquisitions after agreeing to sell its generic-drug business for $40.5 billion. The deal with Teva Pharmaceutical Industries Ltd. “gives us a tremendous amount of flexibility to think about transformational M&A as well as continue our pattern of tuck-in acquisitions,” Allergan Chief Executive Officer Brent Saunders said on a conference call today.
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] next »